| Bioactivity | (Rac)-HA14-1 is the racemic form of HA14-1 (HY-12011). HA14-1 is a Bcl-2/Bcl-xL antagonist with an IC50 of approximately 9 μM against Bcl-2[1]. |
| CAS | 927635-64-1 |
| Formula | C17H17BrN2O5 |
| Molar Mass | 409.23 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Azmi AS, et al. Non-peptidic small molecule inhibitors against Bcl-2 for cancer therapy. J Cell Physiol. 2009 Jan;218(1):13-21. |
(Rac)-HA14-1
CAS: 927635-64-1 F: C17H17BrN2O5 W: 409.23
(Rac)-HA14-1 is the racemic form of HA14-1 (HY-12011). HA14-1 is a Bcl-2/Bcl-xL antagonist with an IC50 of approximately
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.